The Latest Breaking News from Zimmer Biomet Holdings

Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99.

Benzinga · Aug 7, 2025

1 Stock to Buy ASAP to Cash in on the Pickleball Craze

As pickleball injuries rise, this medical device stock is perfectly positioned to cash in on the sport’s booming popularity.

Barchart · Mar 16, 2025

3 High-Growth MedTech Stocks to Buy

The medtech industry’s long-term growth is fueled by growing demand for medical devices, adoption of cutting-edge technologies, and improved efficiency. Thus, it could be ideal to buy fundamentally solid medtech stocks Baxter International (BAX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC) poised for substantial growth. Keep reading.

StockNews.com · Aug 26, 2024

Zimmer Biomet: Q1 Earnings Insights

  Zimmer Biomet Holdings (NYSE:ZBH) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga · May 3, 2022

Abbott Laboratories vs. Zimmer Biomet Holdings: Which Medical Device Stock is a Better Buy?

The medical devices industry is thriving and the integration of advanced technologies position the industry well for growth. Therefore, prominent players in this space, Abbott Laboratories (ABT) and Zimmer Biomet Holdings (ZBH), should benefit. But which of these stocks is a better buy now? Read more to find out.

StockNews.com · Apr 18, 2022

Friday Is Your Last Chance To Buy Zimmer Biomet Holdings Before The Dividend Payout

Friday marks the last chance for investors to receive the next dividend payout from Zimmer Biomet Holdings (NYSE:ZBH).

Benzinga · Mar 23, 2022

Analyst Ratings For Zimmer Biomet Holdings

Analysts have provided the following ratings for Zimmer Biomet Holdings (NYSE:ZBH) within the last quarter:

Benzinga · Mar 21, 2022

Where Zimmer Biomet Holdings Stands With Analysts

Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings within the last quarter:

Benzinga · Mar 2, 2022

Should You Scoop Up Shares of Zimmer Biomet Holdings on the Dip?

The shares of healthcare products and solutions provider Zimmer Biomet (ZBH) plunged in price after the company posted a dismal fourth-quarter earnings report. The company cited pandemic-induced challenges as having hampered its performance, while also anticipating these challenges will persist this year. So, will ZBH’s stock be able to gain…

StockNews.com · Feb 16, 2022

What 16 Analyst Ratings Have To Say About Zimmer Biomet Holdings

Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings within the last quarter:

Benzinga · Feb 8, 2022